awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27026476-EEA23578-2E5E-4938-BB7E-C72BE193F7F5
Q27026476-EEA23578-2E5E-4938-BB7E-C72BE193F7F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27026476-EEA23578-2E5E-4938-BB7E-C72BE193F7F5
Asparaginase pharmacokinetics and implications of therapeutic drug monitoring
P2860
Q27026476-EEA23578-2E5E-4938-BB7E-C72BE193F7F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27026476-EEA23578-2E5E-4938-BB7E-C72BE193F7F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
423196170b1af34722b2571e601cad22d1e5efdb
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).